🟢 Citius Pharmaceuticals is trading 6.95% up today with Nasdaq and S&P 500 higher

Citius Pharmaceuticals is trading at $0.62 (+6.95%) as broader markets gain.

• The stock is rebounding after several volatile sessions, including a 25.62% decline on August 17.
• No fresh company-specific catalyst was identified for August 25, 2026; the Nasdaq Composite rose 0.69% and the S&P 500 rose 0.37%.
• Investors continue weighing Nasdaq’s extension through February 8, 2027, to regain the $1.00 minimum bid requirement, leaving listing risk unresolved.